Review on Chinese Adverse Drug Reaction Information Bulletin and Its Problems

Abstract

Abstract: Chinese Adverse Drug Reaction Information Bulletin is one of the earliest risk control measures established in our country. From 2001 to 2014, a total of 65 issues were released which has played a positive role in promoting China's adverse drug reaction monitoring and protecting public safety. In this paper, the comprehensive review and analysis of the existing problems were conducted about Chinese Adverse Drug Reaction Information Bulletin , in order to make medical professionals learn more about the work and promote the development of adverse drug reaction monitoring.

Key words: Adverse Drug reaction Information Bulletin, review, questions

CLC Number:

R994.11

TIAN Chun-hua, XIA Dong-sheng, LIU Cui-li, GAO Jian-chao . Review on Chinese Adverse Drug Reaction Information Bulletin and Its Problems[J]. Chinese Journal of Pharmacovigilance, 2015, 12(9): 531-533.

References

[1] 国家食品药品监督管理总局药品评价中心. 药品不良反应信息通报(第1期)[EB/OL].(2001-11-19)[2015-08-26].http://www.cdr-adr.org.cn/xxtb_255/ypblfyxxtb/index_5.html.
[2] 国家食品药品监督管理总局药品评价中心. 药品不良反应信息通报(第2期)[EB/OL].(2002-07-01)[2015-08-26].http://www.cdr-adr.org.cn/xxtb_255/ypblfyxxtb/index_5.html.
[3] 国家食品药品监督管理总局药品评价中心. 药品不良反应信息通报(第3期)[EB/OL].(2003-01-01)[2015-08-26]. http://www.cdradr.org.cn/xxtb_255/ypblfyxxtb/index_5.html.
[4] 国家食品药品监督管理总局. 药品不良反应信息通报(第4期)[EB/OL].(2003-09-01)[2015-08-26].http://www.cfda.gov.cn/WS01/CL0078/51284.html.
[5] 国家食品药品监督管理总局. 药品不良反应信息通报(第5期)[EB/OL].(2003-01-23)[2015-08-26].http://www.cfda.gov.cn/WS01/CL0078/11277.html.
[6] 国家食品药品监督管理总局. 药品不良反应信息通报(第6期)[EB/OL].(2004-04-15)[2015-08-26]. http://www.cfda.gov.cn/WS01/CL0078/11278.html.
[7] 国家食品药品监督管理总局. 药品不良反应信息通报(第7期)[EB/OL].(2004-01-17)[2015-08-26]. http://www.cfda.gov.cn/WS01/CL0078/11279.html.
[8] 国家食品药品监督管理总局. 药品不良反应信息通报(第8期)[EB/OL].(2005-04-12)[2015-08-26]. http://www.cfda.gov.cn/WS01/CL0078/11280.html.
[9] 国家食品药品监督管理总局. 药品不良反应信息通报(第10期)[EB/OL].(2006-02-08)[2015-08-26]. http://www.cfda.gov.cn/WS01/CL0078/11282.html.
[10] 国家食品药品监督管理总局. 药品不良反应信息通报(第13期)[EB/OL].(2007-10-29)[2015-08-26]. http://www.cfda.gov.cn/WS01/CL0078/25995.html.
[11] 国家食品药品监督管理总局. 药品不良反应信息通报(第14期)[EB/OL].(2008-07-10)[2015-08-26]. http://www.cfda.gov.cn/WS01/CL0078/31220.html.
[12]国家食品药品监督管理总局. 药品不良反应信息通报(第20期)[EB/OL].(2009-03-24)[2015-08-26]. http://www.cfda.gov.cn/WS01/CL0078/36756.html.
[13] 国家食品药品监督管理总局. 药品不良反应信息通报(第32期)[EB/OL].(2010-09-19)[2015-08-26]. http://www.cfda.gov.cn/WS01/CL0078/53951.html.
[14] 国家食品药品监督管理总局. 药品不良反应信息通报(第47期)[EB/OL].(2012-05-17)[2015-08-26].http://www.cfda.gov.cn/WS01/CL0078/71745.html.
[15] 国家食品药品监督管理总局. 药品不良反应信息通报(第63期)[EB/OL].(2014-09-23)[2015-08-26]. http://www.cfda.gov.cn/WS01/CL0078/106757.html.
[16] 国家食品药品监督管理总局. 国家药品不良反应监测年度报告(2014年)[EB/OL].(2015-07-17)[2015-08-02].http://www.cfda.gov.cn/WS01/CL0078/124407.html